0.05Open0.05Pre Close0 Volume672 Open Interest1.00Strike Price0.00Turnover8762.51%IV12.84%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.3095Delta1.5693Gamma21.80Leverage Ratio-19.8659Theta0.0000Rho-6.75Eff Leverage0.0000Vega
Protalix Biotherapeutics Stock Discussion
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...
positive EMA to be anounced. Possibly as early as tommorow
Here are the notable stocks with the highest and lowest implied volatility.
The $First Republic Bank (FRC.US)$, $ImmunoGen (IMGN.US)$, and $Protalix Biotherapeutics (PLX.US)$has the highest implied volatility of all s...
No comment yet